AMP Rapid Test SARS-CoV-2 Ag
AMP Rapid Test SARS-CoV-2 Ag
AMEDA Labordiagnostik GmbH
Export this page in pdf
Disease target
SARS-CoV-2
Regulatory status
CE-IVD
Germany BfArM
Time to result
0.25
Assay target
Antigen
Test format
Rapid diagnostic test (strip or cassette)
Technology principle
Lateral Flow Assay
Target analyte
N protein
Level of automation
Manual
Laboratory/Point-of-care
True Point of Care
Self-testing/Self-Collection
Intended for professional use only
Validated sample types
Nasal swab
Nasopharyngeal swab
Oropharyngeal swab
Connectivity
No
IMPACT OF SARS-COV-2 VARIANT:
Alpha -
No expected impact (in silico analyses)
Beta -
No expected impact (in silico analyses)
Gamma -
No expected impact (in silico analyses)
Manufacturer performance data
Sensitivity
97.3%
Specificity
100%